120 related articles for article (PubMed ID: 8923280)
21. Exposure control plans define risks for bloodborne pathogen infections.
Muir TW
Occup Health Saf; 1994 Apr; 63(4):75-8, 80. PubMed ID: 9156428
[No Abstract] [Full Text] [Related]
22. Double, double, toil and trouble: infections still spreading in long-term-care facilities.
Bradley SE
Infect Control Hosp Epidemiol; 2005 Mar; 26(3):227-30. PubMed ID: 15796272
[No Abstract] [Full Text] [Related]
23. Potential bacterial cross-contamination using pillboxes in the hospital.
Dussart C; Mazenot C; Lamand V; Chevalier B; Grelaud G
Am J Infect Control; 2010 Jun; 38(5):419-20. PubMed ID: 20569850
[No Abstract] [Full Text] [Related]
24. Infection complicating bone marrow transplantation: what are the risks and can they be reduced?
Rogers TR
J Hosp Infect; 1982 Jun; 3(2):105-9. PubMed ID: 6181127
[No Abstract] [Full Text] [Related]
25. Contamination during in vitro processing of bone marrow for transplantation: clinical significance.
Lazarus HM; Magalhaes-Silverman M; Fox RM; Creger RJ; Jacobs M
Bone Marrow Transplant; 1991 Mar; 7(3):241-6. PubMed ID: 2059759
[TBL] [Abstract][Full Text] [Related]
26. [Protected environment-prophylactic antibiotic program for autologous bone marrow transplantation. Intestinal decontamination for infection prevention (author's transl)].
Funada H; Teshima H; Hattori K
Kansenshogaku Zasshi; 1981 Apr; 55(4):221-33. PubMed ID: 6793672
[No Abstract] [Full Text] [Related]
27. Infections in bone marrow transplant patients: use of reverse-barrier isolation.
Pretnar J; Cernelc P; Mlakar U
Transplant Proc; 1992 Oct; 24(5):2033. PubMed ID: 1412961
[No Abstract] [Full Text] [Related]
28. [The role of measures of personal hygiene in the prevention of infections in autologous bone marrow transplantation. Results of a randomized prospective study].
Rasero L; Errico A; Puccetti M; Tellarini G
Riv Inferm; 1996; 15(3):127-30. PubMed ID: 9001061
[TBL] [Abstract][Full Text] [Related]
29. Quantifying bacterial transfer from patients to staff during burns dressing and bed changes: implications for infection control.
Bache SE; Maclean M; Gettinby G; Anderson JG; MacGregor SJ; Taggart I
Burns; 2013 Mar; 39(2):220-8. PubMed ID: 23318217
[TBL] [Abstract][Full Text] [Related]
30. Bioterrorism watch. Clinicians must be voice of reason, reassurance now that bioterrorism battle has been joined.
Evans G
ED Manag; 2001 Nov; 13(11):suppl 1-4, suppl 1. PubMed ID: 11725496
[No Abstract] [Full Text] [Related]
31. Survey of infection control policies for patients with cystic fibrosis in the United States.
Zhou J; Garber E; Saiman L
Am J Infect Control; 2008 Apr; 36(3):220-2. PubMed ID: 18371519
[TBL] [Abstract][Full Text] [Related]
32. The study of a contaminated colonoscope.
Muscarella LF
Clin Gastroenterol Hepatol; 2010 Jul; 8(7):577-80.e1. PubMed ID: 20610350
[No Abstract] [Full Text] [Related]
33. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
[TBL] [Abstract][Full Text] [Related]
34. [The effects of preventive regimens for the prophylaxis of infection after bone marrow transplantation].
Morishima Y; Yanada M; Kamiya Y; Shimokawa T; Kitaori K; Sakai K; Banno A; Sao H
Rinsho Ketsueki; 1997 Feb; 38(2):108-16. PubMed ID: 9059064
[TBL] [Abstract][Full Text] [Related]
35. Preventing the Transfer of Pathogenic Organisms From the Use of Mobile Phones.
McGoldrick M
Home Healthc Now; 2016 Jan; 34(1):45. PubMed ID: 26645845
[No Abstract] [Full Text] [Related]
36. Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased safety in the transplant ward.
Gorin NC; Fouillard L
Pathol Biol (Paris); 1992 Nov; 39(9):954-5. PubMed ID: 1538950
[No Abstract] [Full Text] [Related]
37. Infection in bone-marrow recipients.
Winston DJ; Ho WG; Gale RP
Ann Intern Med; 1979 Apr; 90(4):715-6. PubMed ID: 373557
[No Abstract] [Full Text] [Related]
38. Adverse reactions in patients transfused with cryopreserved marrow.
Stroncek DF; Fautsch SK; Lasky LC; Hurd DD; Ramsay NK; McCullough J
Transfusion; 1991; 31(6):521-6. PubMed ID: 1853447
[TBL] [Abstract][Full Text] [Related]
39. Present status of bone marrow transplantation in Japan.
Masaoka T
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1491-8. PubMed ID: 3551434
[No Abstract] [Full Text] [Related]
40. Control of infections caused by drug-resistant organisms in critical care.
Hoppe B
Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
